Search for: "Rivas v. State" Results 101 - 109 of 109
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2021, 8:08 am by Dan Bressler
” “‘Within days’ of the Sept. 19, 2019, receipt of the fourth letter, Houston and Rivas ran it by Reed Smith’s in-house counsel and the California State Bar’s ethics hotline, the panel said. [read post]
29 Nov 2017, 4:23 pm by Jeff Kern and Kate Ross*
The annual report states that under Clayton, pursuit of individuals will be the rule rather than the exception.[12] One justification for this strategy is deterrence. [read post]
1 Dec 2017, 2:55 pm by Jeff Kern and Kate Ross*
The annual report states that under Clayton, pursuit of individuals will be the rule rather than the exception.[12] One justification for this strategy is deterrence. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]